Screening method for identifying women at increased risk for imminent delivery
US5516702A · kind A · utility
60Cited by
1References
9Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Jun 29, 1994 |
| Grant date | May 14, 1996 |
| Priority date | — |
| Expiry date | Jun 29, 2014 |
Classification
- Technology area (CPC Y)Emerging Cross-Sectional Technologies
- CPC primaryY10S436/814
- WIPO fieldMeasurement
- WIPO sectorInstruments
Abstract
The present invention provides an early, biochemical indication of increased risk of impending preterm delivery. The method comprises obtaining a cervicovaginal secretion sample from a pregnant patient after week 12 of gestation and determining the level of a local inflammatory product protein in the sample. The presence of an elevated level of the selected protein in the sample indicates an increased risk of delivery. The test is a screening assay that can detect women at risk of imminent delivery, as early as two to three weeks prior to delivery.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.